Comparing two IV steroid schedules for Graves' eye disease
Treatments studied
Part of Eyes & vision, Genetic & congenital, Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests two different ways of giving a steroid medicine (methylprednisolone) through an IV to treat active Graves' eye disease. The goal is to see which approach works better and is safer for people with moderate to severe symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have moderate to severe Graves' eye disease (thyroid eye disease) that is active (showing signs of inflammation like redness, swelling, or pain).
- Your thyroid hormone levels have been stable (normal) for at least 2 months, and you have been treated with antithyroid drugs, surgery, or have waited 6 months after radioactive iodine.
- You have never received treatment that suppresses your immune system specifically for your thyroid eye disease.
- You have not used steroids or other immune-suppressing drugs in the last 3 months for any reason.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether high-dose steroid pulses (given through a vein) can help people with moderate to severe Graves' eye disease that is still active. It is for people who have not yet been treated with steroids and whose eye problems began within the past year.
This study tests whether the cholesterol-lowering drug atorvastatin can help people with active, moderate-to-severe thyroid eye disease (swelling and bulging of the eyes caused by an overactive thyroid). You will receive the drug or a placebo alongside your usual steroid treatment, and your eyes will be checked over about a year.
This trial studies whether hydroxychloroquine can improve mild Graves’ orbitopathy (swelling and discomfort around the eyes). It’s meant for people with mild symptoms and who haven’t recently used certain eye or immune treatments.
This trial tests whether simvastatin (a cholesterol medicine) can improve eye symptoms from Graves’ eye disease. It is aimed at people with active mild-to-moderate disease and will also check safety with blood tests, heart/skin tolerance, and stomach health.
This trial tests a modified orbital decompression surgery to treat moderate-to-severe swelling and bulging of the eyes caused by Graves' disease. It aims to improve eye function and appearance for people whose thyroid condition has been stable for at least 6 months.
This trial tests if low-level light therapy can improve dry eye symptoms in people with Graves' disease whose dry eyes haven't gotten better with standard treatments like artificial tears.
Hear when a new Graves Ophthalmopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.